Trabajo presentado en el ESMRMB 38th Annual Scientific Meeting, celebrado en modalidad virtual del 07 al 09 de octubre de 2021.[Introduction]: Different orthotopic murine preclinical models have been developed to study the diagnosis, progression and therapy validation of glioblastoma multiforme (GBM)1, the most frequent and lethal malignant brain tumor2. Among them, the xenograft model established by stereotactic injection of the human G144 stem cells emerges as one of the best approaches to replicate the human GBM features in immunocompromised mice and to address GBM genetics and histopathology3,4,5. Magnetic resonance imaging (MRI) is a powerful tool to obtain structural, functional and molecular information on the physiopathology of intr...
Glioblastoma multiforme (GBM) is a unique aggressive tumor and mostly develops in the brain, while r...
Glioblastoma Multiforme (GBM) is the most common form of primary brain cancer that has an extremely ...
The clinical translation of new nanoparticle-based therapies for high-grade glioma (HGG) remains ext...
Trabajo presentado en el ESMRMB 38th Annual Scientific Meeting, celebrado en modalidad virtual del 0...
Trabajo presentado en el 37th Annual Meeting; European Society for Magnetic Resonance In Medicine an...
Purpose To assess glioblastoma multiforme (GBM) formation with similar imaging characteristics to hu...
Trabajo presentado en el ESMRMB 38th Annual Scientific Meeting, celebrado en modalidad virtual del 0...
SUMMARY: Murine models are the most commonly used and best investigated among the animal models of H...
Glioblastoma (GBM) is the most common and aggressive form of primary malignant brain cancer. Treatme...
Glioblastoma (GBM) is the most common form of brain tumor characterized by its resistance to convent...
Trabajo presentado en el 1st ISMRM Iberian Chapter Annual Meeting, celebrado en Portugal del 16 al 1...
Glioblastoma multiforme (GBM) is a lethal and incurable disease. The C6 rat model of GBM shares seve...
Abstract Animal models greatly facilitate understanding of cancer and importantly, serve pre-clinica...
Glioblastoma is the most common and most aggressive type of brain tumor, with an almost 100 % mortal...
abstract: Glioblastoma Multiforme (GBM) is an aggressive and deadly form of brain cancer with a medi...
Glioblastoma multiforme (GBM) is a unique aggressive tumor and mostly develops in the brain, while r...
Glioblastoma Multiforme (GBM) is the most common form of primary brain cancer that has an extremely ...
The clinical translation of new nanoparticle-based therapies for high-grade glioma (HGG) remains ext...
Trabajo presentado en el ESMRMB 38th Annual Scientific Meeting, celebrado en modalidad virtual del 0...
Trabajo presentado en el 37th Annual Meeting; European Society for Magnetic Resonance In Medicine an...
Purpose To assess glioblastoma multiforme (GBM) formation with similar imaging characteristics to hu...
Trabajo presentado en el ESMRMB 38th Annual Scientific Meeting, celebrado en modalidad virtual del 0...
SUMMARY: Murine models are the most commonly used and best investigated among the animal models of H...
Glioblastoma (GBM) is the most common and aggressive form of primary malignant brain cancer. Treatme...
Glioblastoma (GBM) is the most common form of brain tumor characterized by its resistance to convent...
Trabajo presentado en el 1st ISMRM Iberian Chapter Annual Meeting, celebrado en Portugal del 16 al 1...
Glioblastoma multiforme (GBM) is a lethal and incurable disease. The C6 rat model of GBM shares seve...
Abstract Animal models greatly facilitate understanding of cancer and importantly, serve pre-clinica...
Glioblastoma is the most common and most aggressive type of brain tumor, with an almost 100 % mortal...
abstract: Glioblastoma Multiforme (GBM) is an aggressive and deadly form of brain cancer with a medi...
Glioblastoma multiforme (GBM) is a unique aggressive tumor and mostly develops in the brain, while r...
Glioblastoma Multiforme (GBM) is the most common form of primary brain cancer that has an extremely ...
The clinical translation of new nanoparticle-based therapies for high-grade glioma (HGG) remains ext...